Normal fibroblasts in medium containing 0.02 mM CaC12 arrested growth within 24 hr, whereas Duchenne muscular dystrophy fibroblasts continued to grow for 5 days, albeit at 40% of their rate in standard medium (1.8 mM CaCI2). Moreover, Duchenne cells in calcium-deficient medium showed an enhanced rate of protein synthesis (60% over the rate in standard medium), whereas normal cells were unaffected. Previously we described a general assay for detection of mutant cells by using herpes simplex virus I replication as a probe of cellular function. By altering the growth medium, one can elicit changes in viral DNA replication that depend upon cellular differences. Duchenne fibroblasts in calcium-deficient low-serum (0.5%) medium supported viral replication at a rate 7-to 10-fold greater than did normal cells infected under the same conditions. Using this viral assay, we have successfully identified all 10 samples of a blind coded set of Duchenne muscular dystrophy, normal, and heterozygote cells. In addition, differences of a lower magnitude were found between these cell strains as measured by cellular growth or protein synthesis. Therefore, a cell's ability to grow and support viral replication in calcium-deficient medium can be used to readily distinguish Duchenne muscular dystrophy fibroblasts from normal ones. These results suggest that the viral assay could be used as a prenatal diagnostic test. A defect related to calcium metabolism may be fundamental to this disease.
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to be abnormal in DMD cells (3) . Additionally, Gruenstein and co-workers have reported an increase in Cl-efflux in DMD fibroblasts (6) . Many of the abnormalities observed in DMD can be explained by an elevated intracellular Ca2+ level, and many biochemical and physiological anomalies peculiar to DMD cells can be reproduced by artificially increasing intracellular Ca2+ (7) .
We explored the possibility that the inability of DMD cells to properly regulate ion balances, particularly Ca2 , might result in altered growth properties. We describe here large differential effects of extracellular Ca2+ and of drugs that interfere with ion regulation on cellular and viral growth in normal and DMD fibroblasts.
We have described an assay for the detection of mutant cells by using herpes simplex virus I (HSV-I) replication as a probe of cellular function (8) . The assay relies on affecting cellular metabolism by altering growth conditions, thus eliciting changes in intracellular viral DNA replication. In the present study, we demonstrate that the viral assay readily and rapidly distinguishes DMD from normal fibroblasts by their ability to support viral replication in Ca2'-deficient medium or in the presence of Ca '-related drugs. Our findings provide a basis for the development of a prenatal diagnostic test for DMD, may contribute to an understanding of the primary defect, and have implications for a therapeutic approach.
Duchenne muscular dystrophy (DMD) is an X-linked recessive disease, affecting about one in every 3000 males born. It is manifest as progressive and severe muscle degeneration beginning very early in life and culminating in death by the second or third decade. In addition to muscle involvement, affected individuals have cardiac abnormalities and high serum levels of several enzymes involved in energy metabolism. Numerous cellular and biochemical abnormalities have been demonstrated in muscle, nerve, erythrocyte, and fibroblastic cells of DMD patients (1-3). The primary defect in DMD has not been identified. Although many hypotheses have been proposed to explain the disease, none have resulted in an accurate prenatal diagnostic test or a successful therapeutic regimen.
The earliest detectable abnormality in DMD is a dramatically increased serum creatine kinase (4) . Abnormal serum levels are highest at birth, before any measurable muscle degeneration has occurred, and are thought to result from leakage into the blood stream from muscle cells. Several investigators have therefore suggested that a defect in plasma membrane function might explain this unusual finding (5) . Misregulation of ionic balance would have profound effects on plasma membrane integrity, particularly in nerve and muscle function. Various cationic fluxes have been reported MATERIALS AND METHODS Cell Culture. Cells were routinely grown in a water-saturated atmosphere (10% C02/90% air) at 37°C in 75-cm2 flasks (Falcon). The medium was Dulbecco's modified Eagle's medium (DME medium, Flow Laboratories) supplemented with 10% fetal calf serum, plus added glutamine (4 mM final concentration), and for the chorionic villi and fetal cells, penicillin (100 units/ml) and streptomycin (100 ,g/ml). Cells grown in the presence of antibiotics were passaged at least once without antibiotics before using them in experimental cultures. We noticed that the presence of these drugs depressed the magnitude of our results. Every [3] [4] Viral Assay. HSV-I was obtained, grown, and assayed as previously described (8) . Cells (4-5 x 104) were plated in triplicate 16 -mm wells. The medium was aspirated 12-36 hr later, the cells were washed twice with P,/NaCI, and 1 ml of the appropriate pretreatment medium was added. After the pretreatment period (24-48 hr), the medium was aspirated and HSV-I (2 x 104 plaque-forming units) plus tetrahydrouridine at 10 tug/ml in the appropriate medium was added in a total volume of 0.3 ml. Viral adsorption and penetration was allowed for 2 hr at 370C, and then 10 ILI of [12 I ]iododeoxycytidine (125IdCyd) (New England Nuclear, 2200 Ci/mmol, 2.8 ACi/ml; 1 Ci = 37 GBq) was added. The use of 125IdCyd to measure HSV-I replication and tetrahydrouridine to block cellular isotope utilization has been described (10) . After 14-17 hr of additional incubation, isotope incorporation was stopped by addition of two drops of 1 M ascorbic acid, cells were washed twice with cold P,/NaCl, and 1 ml of cold 10% trichloroacetic acid was added. After 15-20 min at 4°C, trichloroacetic acid was removed, cells were washed again with cold trichloroacetic acid, 0.5 ml of 0.2 M NaOH was added, and solubilization was allowed for 15-20 min in a 37°C warm room. A 300-,ul sample of the NaOH solution was then added to 5 ml of scintillation cocktail (Biofluor, New England Nuclear) and radioactivity was measured on the open channel of a liquid scintillation counter (LS9000, Beckman).
DNA ard Protein Synthesis. Cells were plated as for growth determinations. Twenty-four hours after plating, cells were washed twice with P,/NaCl, and DME medium (0-1.8 mM Ca2+) and dialyzed fetal calf serum as indicated were added back. After an additional 24-to 48-hr incubation, cells were pulsed for 30 Table   1 ). The rates were not widely different for several strains in 1.8 mM Ca2+, and for the normal cells the rates in 1.8 and 0.02 mM Ca2+ were similar. But in the DMD cells and a carrier strain, the rate was about 60% higher in the Ca2+-deficient medium.
Serum starvation causes 3T3 cells to stop proliferating and to sequester Ca2+ into intracellular stores, thereby restricting its availability (13) . This effect is reversible; DNA synthesis resumes and stored Ca2+ is extruded when serum is added back to these cells. To explore these observations in relation to DMD, we looked at the effect of serum starvation and Ca2+ depletion on DNA synthesis and cell growth. Normal cells that were serum (1%) or calcium (0 mM Ca2+ + 1 mM EGTA) starved for 28 hr were growth arrested, while some cell strains showed cell death. In contrast, DMD cells Optimization of a Viral Assay to Identify DMD Cells. We have previously described a method for assessing cellular function that uses HSV-I growth as an indicator (10) . A cell's ability to support viral replication can be a rapid, sensitive, and accurate probe of altered metabolism and is independent of cell growth. HSV-I replication was assessed by radioisotope (125IdCyd) incorporation. 125IdCyd is a good substrate for HSV-I-encoded thymidine kinase (TK) but a poor one for the cellular enzyme. 125IdCyd incorporation into trichloroacetic acid-precipitable material is proportional to the amount of viral DNA replication (10) . We therefore attempted to enhance the Ca "-dependent differences between DMD and normal fibroblasts found in growth assays.
Normal and DMD fibroblasts were infected with HSV-I under a variety of conditions, as summarized in Table 3 . After the Ca2+ concentration had been lowered from 1.8 mM to 0.02 mM, 125IdCyd incorporation in DMD cells was 50% greater than in normal fibroblasts. When cells were infected in Ca2'-deficient medium and further stressed by the addition of a calcium antagonist or by lowering the serum concentration to 0.5%, the difference between DMD and normal cells was 5-to 10-fold. For example, the ability of DMD cells to support viral replication after 24-hr pretreatment and infection in Ca2'-and serum-deficient medium only slightly decreased virus-specific isotope incorporation (70% of control) compared to normal cells, which barely supported viral replication (16% of control).
On the basis of our results indicating that LiCl enhanced the growth of DMD cells, we also looked at the effect of LiCl and other calcium antagonists on viral replication (Table 3) . Ca2'-deficient medium plus various added calcium antagonists produced 50-200% differences between DMD and normal cells. LiCl (2.5 mM) added to DMD cells in 0.02 mM Ca2+ had no effect on 125IdCyd viral incorporation but in nor- Results are expressed as the percent change from the initial density at the time cells were shifted to low serum or low Ca2 .
*Blind-tested cells. mal cells it inhibited viral incorporation by 60%. LiCl at 5 mM inhibited viral growth in DMD cells to 47% of controls, while in normal cells viral replication was further reduced to 24%.
A lithium-specific ionophore, AS701, recently has been synthesized (14) . We expected that this drug might lower the dose of LiCl inhibitory in the viral assay. Unexpectedly, the greatest difference between DMD and normal fibroblasts was obtained in cells treated with 1.0 ,M AS701 in Ca2+-deficient medium (0.02 mM) with no added LiCl. DMD cells infected in the presence of LiCl (2.0 mM) and AS701 in Ca2+-deficient medium supported viral replication at 50% of the control compared to 30% in normal cells. Thus, this dosage of LiCl together with the ionophore proved to be inhibitory in both cell strains. However, with the ionophore alone in Ca2+-deficient medium, viral 125IdCyd incorporation in DMD cells was similar to that in control cultures, while incorporation in normal cells was reduced to 45% of the control.
Although AS701 has a good selectivity for various ions present in biological systems (e.g., 0.07 for Na+ compared to 1.0 for Li+) (15) , the relatively high concentration of NaCl (150 mM) in the medium compared to LiCl (2.0-10.0 mM) could permit AS701 to act as a Na+ ionophore. To test this possibility, normal and DMD cells were infected with HSV-I in the presence of monensin (a Na+ ionophore) in low (0.02 mM) or normal (1.8 mM) Ca2+ medium (no LiCl), and virusspecific 125IdCyd incorporation was measured (Table 3) .
Monensin inhibited viral growth in normal cells by 50% and in DMD cells by 5%, a result similar to that obtained with AS701. This supports the idea that AS701 in physiological saline acts similarly to monensin, transporting Na+ rather than Li+, and thus depressing viral DNA synthesis.
A number of drugs may affect Ca2+-dependent metabolism: dantrolene, a muscle relaxant, is thought to act by blocking the release of Ca2+ from the sarcoplasmic reticulum; verapamil is a Ca2+ channel blocker. In each case we found that DMD cells were less sensitive to these drugs than were normal cells, as measured by viral 125IdCyd incorporation in Ca2+-deficient media.
If the greater ability of DMD cells to replicate virus in Ca2+-deficient medium is due to higher internal Ca2+ levels, then raising the level of Ca2+ in the medium might further stress DMD cells and interfere with their ability to support viral replication. Normal Blind Tests. After optimizing conditions for differentiating normal from DMD cells, we arranged to have a blind, coded set of fibroblasts sent to our laboratory (courtesy of Eric Gruenstein). These were fibroblasts from DMD patients, obligate carriers, and normal controls. We identified with 100% accuracy all of the unknown cell types (n = 10), using the viral assay, by infecting the cells in Ca2+-and serum-deficient medium (Table 4) .
Assay of cell growth in Ca2+-deficient medium similarly allowed us to distinguish these coded cells ( did their controls in DME medium, while the normal amniotic cells incorporated the label only 31% as well.
DISCUSSION
We find that DMD fibroblasts can be distinguished from normal fibroblasts by their greater ability to grow, synthesize protein, and support viral replication in a medium deficient in Ca2 , serum, or both. Normal cells arrested growth in serum-or Ca2'-deficient medium, while DMD cells were far more refractory to starvation conditions. It has been reported that serum growth factors reduce the Ca2+ requirement for cellular proliferation (17) . In addition, a decrease in the cellular requirement for Ca2+ has been correlated with a reduced serum requirement for growth (18) . The mechanism(s) by which Ca2+ and serum interact to control growth is not yet clear. Further studies are necessary to determine the exact relationship between the reduced Ca2+ requirement and the reduced serum requirement for cellular proliferation in DMD fibroblasts. Although the above characteristics are often observed in transformed cells, DMD fibroblasts do not behave like transformed cells with respect to saturation density or anchorage-dependent growth. Moreover, eventually DMD cells do cease proliferation after Ca2+ or serum starvation.
We have found that DMD and normal cells respond very differently to a variety of drugs that perturb intracellular Ca2 . All of these results can be explained by DMD cells having an abnormally high intracellular Ca2+ concentration. For instance, we found that DMD cells treated with the sodium ionophore monensin (or the lithium ionophore AS701) supported viral replication at a higher rate than did normal cells. One possible explanation for this result is that these ionophores transport Na' into the cell via the Na'-Ca2+ antiporter. This would allow extrusion of intracellular Ca2+ in exchange for Na+, and thus would alleviate the high intracellular Ca2+ in DMD cells. These effects are seen only in Ca2+-deficient medium in the absence of Li', thus suggesting that they are Ca2+ and not Li' related.
Preliminary results suggest that the viral assay could be utilized as an efficient, accurate, and quick method for detecting DMD prenatally after amniocentesis or possibly chorionic villi biopsy. Very early DMD fetal muscle contains an increased calcium concentration (19) , demonstrating that a defect in Ca2+ metabolism is expressed quite early in the disease, and well before actual muscle wasting has occurred. Our results demonstrate that a defect is also manifest in nonnerve or muscle cells (fibroblasts). Although these results are encouraging and consistent with those found in fibroblast cells of nonfetal origin, caution must be exercised in comparing the two cell strains. The normal amniotic cells were a primary culture and GM2339 is passaged cell strain containing fibroblastic cells. A more definitive validation of the viral assay in amniotic cells will be dependent upon our ability to obtain additional cultures from confirmed DMD fetuses.
Recent advances in molecular genetics suggest that rapid progress can be expected toward the identification of the DMD gene (20) . At the present time, however, there exists no means of identifying cloned DNA containing such a gene. Our finding of differential growth conditions for normal and DMD cells, and the ability of the viral assay to quickly distinguish these cells, may be especially useful for selection of transfectants in screening recombinant clones.
